Vazyme(SH:688105) Zheng Quan Zhi Xing·2025-09-01 16:10Summary of Key Points Core Viewpoint - The company, Nanjing Novogene Bioinformatics Technology Co., Ltd., has announced a share repurchase plan aimed at enhancing employee stock ownership and incentivizing staff, with a total expected repurchase amount between 5 million and 10 million RMB [1][2]. Group 1: Share Repurchase Plan - The share repurchase plan was first disclosed on June 20, 2025, and will be implemented from June 19, 2025, to June 18, 2026 [1]. - The repurchase is intended for employee stock ownership plans or equity incentives, rather than reducing registered capital or converting convertible bonds [1]. - The company has already repurchased 40,000 shares, which accounts for 0.01% of the total share capital [1]. Group 2: Financial Details - The total amount spent on the repurchase so far is 973,800 RMB, with the repurchase price ranging from 24.26 RMB to 24.36 RMB per share [1]. - The maximum repurchase price is set at 30 RMB per share [1]. - The company plans to make repurchases based on market conditions during the specified period [2].